Product Information
DEFERASIROX 180 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.8750 per EA under NDC 70710127603. Its NADAC has been published 53 times since Aug 20, 2025.
FDA first approved this application on Nov 20, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
180 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710127603
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
10/22/2025
Active Ingredients
DEFERASIROXApproval Type
Generic (ANDA)
FDA Application
ANDA211383FDA Approved
11/20/2019
TE Code
AB
On Market Since
6/16/2020
Pharmacological Classes
Price Statistics
The NADAC for DEFERASIROX 180 MG TABLET has been published 53 times since Aug 20, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8750 per EA |
|---|---|
| All-time high | $0.8750 (Aug 19, 2026) |
| All-time low | $0.8750 (Aug 20, 2025) |
| 52-week high | $0.8750 |
| 52-week low | $0.8750 |
| Median price | $0.8750 |
| Average price | $0.8750 |
| Largest weekly change | 0.0% (Aug 27, 2025) |
| Weeks tracked | 53 |
| Tracking since | Aug 20, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the deferasirox market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEFERASIROX 180 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DEFERASIROX 180 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.8750 per EA (NDC 70710127603), effective Aug 19, 2026.
How has the price of DEFERASIROX 180 MG TABLET changed over time?
Over the history we have for it, the NADAC for DEFERASIROX 180 MG TABLET has held within roughly two percent of its current level. It has been tracked across 53 weekly CMS publications since Aug 20, 2025.
What are the highest and lowest recorded NADAC prices for DEFERASIROX 180 MG TABLET?
Since Aug 20, 2025, the NADAC for DEFERASIROX 180 MG TABLET has ranged from a low of $0.8750 (Aug 20, 2025) to a high of $0.8750 (Aug 19, 2026), with a median of $0.8750 per EA.
Are there cheaper alternatives to DEFERASIROX 180 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of DEFERASIROX 180 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEFERASIROX 180 MG TABLET?
DEFERASIROX 180 MG TABLET (NDC 70710127603) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.